NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- Education Critical to Boosting Home Dialysis, Panel Says I Posted 01-16-2026
- The Annual Dialysis Conference Will be in Kansas City, MO February 26 to March 1 Posted 01-16-2026
- The Forum of ESRD Networks has New Videos for its 2023 Home Dialysis Toolkit Posted 01-16-2026
- Vantive: Real People, Real Stories on PD Empowers Site for Patients Posted 12-17-2025

